mixed tumor

英 [mɪkst 'tjuːmə(r)] 美 [mɪkst 'tumər]

混合瘤

医学



双语例句

  1. Conclusion: Most of mixed tumor of parotid gland and Warthin's tumor can be diagnosed exactly by the analysis of MRI findings and clinical material.
    结论:磁共振成像检查的特征表现和临床资料相结合对腮腺多形性腺瘤与沃辛瘤可正确诊断。
  2. The clinical application of treatment mixed tumor of parotid with regional excision
    腮腺区域性切除术治疗多形性腺瘤的临床应用
  3. Mesodermal mixed tumor of corpus uteri
    子宫体混合性中胚层瘤
  4. Reverse and full-exposed method of facial nerve dissection on the treatment of parotid mixed tumor
    全视下逆行法面神经解剖术治疗腮腺混合瘤
  5. The recurrence of benign mixed tumor was statistically related to pathological classification and encapsulates.
    其中良性混合瘤的病理类型和包膜完整性在肿瘤的复发中具有统计学意义。
  6. Immunohistochemical Study on Bcl-2 and PCNA in Mixed Tumor of Skin
    皮肤混合瘤中bcl-2和增殖细胞核抗原的免疫组化研究
  7. Clinical diagnosis is parotid mixed tumor.
    病理诊断:腮腺多形性腺瘤。
  8. Results The CT and MRI manifestations of intracranial mixed tumor were exactly like meningioma, glioma, and hypophysoma, etc, therefore it was usually misdiagnosed the common tumor.
    结果颅内混合瘤的CT、MRI表现酷似脑膜瘤、胶质瘤和垂体瘤等,不熟悉此类肿瘤的临床和病理知识,可错诊为常见肿瘤。
  9. Results The recurrent rate of benign mixed tumor, adenoid cystic carcinoma and malignant mixed tumor was 23. 0%, 18. 2% and 27. 8%, respectively.
    结果良性混合瘤、腺样囊性癌和恶性混合瘤的复发率分别为23.0%、18.2%和27.8%。
  10. Conclusions: There were high malignancy and worse prognosis in bladder mixed tumor.
    结论:膀胱混合癌是一种恶性程度很高的肿瘤,预后差,早期诊断困难。
  11. Malignant mixed tumor ( 33 case-s), mucoepidermoid carcinoma ( 29 cases) and adenoid cystic carcinoma ( 23 cases) were the major pathological types The incidence of lymph node metastasis was 6.9%.
    主要病理类型是恶性混合瘤(33例)、粘液表皮样癌(29例)和腺样囊性癌(23例)。
  12. Cases salivary gland, there were mixed tumor.
    来源于唾液腺的6例,均为唾液腺良性混合瘤;
  13. The distribution of 12 lectin receptors in salivary mixed tumor and malignant mixed tumor and it's significance
    12种凝集素受体在涎腺混合瘤及恶性混合瘤组织中的分布及意义
  14. The benign mixed tumor of lacrimal gland present special problems in diagnosis and management.
    泪腺良性混合瘤是眼眶内常见肿瘤。
  15. EBCT CTS 3 D-CT Flow Scan and MRI Studying of Parotid Mixed Tumor
    腮腺混合瘤的EBCT、CTS、3D-CT、流动扫描和MRI研究
  16. Conclusions: The clinical manifestations of bladder mixed tumor are irritable bladder symptoms.
    结论:膀胱混合癌以膀胱刺激症状为主要临床表现,恶性程度高,早期诊断困难。
  17. Diagnostic curettage is useful for endometrial stromal sarcoma, carcinosarcoma, and malignant mesodermal mixed tumor.
    诊断性刮宫对子宫内膜间质肉瘤、癌肉瘤及恶性中胚叶混合瘤的诊断价值较大;
  18. Conclusion Aberrant expression of bcl-2 and PCNA in mixed tumor of skin may play a role in tumorigenesis.
    结论皮肤混合瘤中bcl-2、PCNA的异常表达似与此肿瘤的发生相关。
  19. The clinical analysis of the postoperative complications of parotid mixed tumor
    腮腺混合瘤术后复发及并发症的预防和处理
  20. Application of regional excision of parotid gland in treatment of mixed tumor
    腮腺区域性切除在混合瘤治疗中的应用
  21. Clinically, this tumor should be different from the mixed tumor, tuberculous lymphadenitis or cyst of the area of parotid.
    临床上应与腮腺混合瘤、淋巴结结核和囊肿相鉴别。
  22. The histogenesis, clinical and pathologic characteristics of the mixed tumor were discussed in detail.
    对尿路复合性恶性肿瘤的组织学、临床和病理特征进行了讨论。
  23. The Benign Mixed Tumor of Lacrimal Gland of CT Finding ( Analysis of 32 Cases)
    泪腺良性混合瘤的CT表现(32例分析)
  24. Bone morphogenetic protein-mediated type II collagen expression in pilomatricoma and cutaneous mixed tumor
    骨形形成蛋白介导的Ⅱ型胶原在毛母质瘤和皮肤混合性肿瘤的表达
  25. Differential diagnosis included bronchial cleft cyst, mixed tumor and some other tumors in the parotid.
    鉴别诊断包括鳃裂囊肿、混合瘤及一些其它腮腺肿瘤。
  26. Methods Bcl-2 and PCNA expression in 12 cases of mixed tumor of skin were studied using immunohistochemical S-P method and double-staining.
    方法采用免疫组化S-P法及免疫组化双染技术对12例皮肤混合瘤皮损标本中bcl-2和PCNA的表达进行观察。
  27. Study of Image and Pathology Ultrastructure and Immunohistochemistry in Intracranial Mixed Tumor
    颅内混合瘤的影像表现与病理超微结构和免疫组化研究
  28. Methods The DNA contents and AgNOR were analysed by flow cytometry and silver staining nucleolar technique for sixty cases of benign unrecurrent, recurrent and malignant parotic gland mixed tumor.
    方法对60例良性无复发、复发和恶性腮腺混合瘤用流式细胞仪和银染色核形成技术作DNA含量和AgNOR定量测定。